SINGAPORE (May 22): QT Vascular is in talks with interested third parties for possible transactions involving its coronary products.

The talks come hot on the heels of the disposal of its Chocolate PTA, its non-drug coated peripheral asset, to global healthcare company Medtronic, for US$28 million ($39 million).

The current talks should not conflict with the Medtronic transaction, says QT Vascular.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook